[Disclosure] Hyundai Motor (005380) – Decision to Dispose of 50,458 Treasury Shares (Approx. KRW 25.28B) to Company Executives Disclosures
[Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product (ALT-B4) / 2026-03-25 Bio & Healthcare
[Disclosure] SK Hynix (000660) – Results of Annual General Meeting of Shareholders / 2026-03-25 Semiconductors
[Disclosure] SK Hynix (000660) – Response to Inquiry Disclosure Request (Unconfirmed) / 2026-03-25 Semiconductors
[Disclosure] SK Square (402340) – Results of Annual General Meeting of Shareholders / 2026-03-25 Semiconductors
[Disclosure] SK Square (402340) – Matters Related to Obligation of Timely Disclosure (Fair Disclosure) / 2026-03-25 Semiconductors
[Disclosure] SK Square (402340) – Decision on Acquisition of Treasury Stocks / 2026-03-25 Semiconductors
[Disclosure] Celltrion (068270) – Execution of License-in Agreement for Microbiome Gut Disease Drug Candidates / 2026-03-25 Disclosures
![[Disclosure] Hyundai Motor (005380) – Decision to Dispose of 50,458 Treasury Shares (Approx. KRW 25.28B) to Company Executives](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-현대차.jpg)
![[Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product (ALT-B4) / 2026-03-25](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환알테오젠.jpg)
![[Disclosure] SK Hynix (000660) – Results of Annual General Meeting of Shareholders / 2026-03-25](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환SK하이닉스-3.jpg)
![[Disclosure] SK Square (402340) – Results of Annual General Meeting of Shareholders / 2026-03-25](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-SK스퀘어.jpg)
![[Disclosure] Celltrion (068270) – Execution of License-in Agreement for Microbiome Gut Disease Drug Candidates / 2026-03-25](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)